Clinical Trial Update: Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

View source ↗

Summary

A suspended clinical trial is exploring a biomarker-guided strategy to reduce common toxicities from conventional chemotherapy in lymphoma and sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Sarcoma

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Lymphoma, Sarcoma | Status: SUSPENDED